Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ISOTOPES HOLDING AS
AS
Active
Org 932730790
Ullernchausséen 64A, 0379 Oslo
Manufacture of basic pharmaceutical products · NACE 2110
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,5M
EBITDA margin
-189.0%
-84798% vs 2023
Equity ratio
38.8%
Financial strength
Net profit 2024
NOK -4,7M
-84522% vs 2023
EBITDA — year on year
NOK millions
0M
-2M
-3M
-5M
-6M
0M
2023
-5M
-500%
2024
Key figures
Annual report 2024
Revenue
NOK 2,5M
—
EBITDA
NOK -4,7M
-84798%
Net profit
NOK -4,7M
-84522%
Total assets
NOK 3M
+9935%
Equity
NOK 1,2M
+4677%
Employees
0
—
Company information
Legal name
ISOTOPES HOLDING AS
Org number
932730790
Legal form
Aksjeselskap
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
28. desember 2023
Share capital
NOK 32 250
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Eie selskaper forbundet med isotopanrikning og videreforedling av anrikede isotoper.
Contact
Address
Ullernchausséen 64A, 0379 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of basic pharmaceutical products
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
0M
2023
3M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
-5M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
2 502
Staff expenses
−0
−0
EBITDA
−6
−4 729
Depreciation & amort.
−0
−0
EBIT
−6
−4 729
Net financials
0
15
Profit before tax
−6
−4 713
Tax
−0
−0
Net profit
−6
−4 713
Balance sheet
NOK thousands
Item
2023
2024
Total assets
30
3 010
Equity
24
1 167
Long-term debt
0
0
Short-term debt
6
1 843
Total debt
6
1 843
Financial ratios
5-year trend
EBITDA margin
-189.0%
This company
15.8%
Market median
-1296% vs market
2023
2024
Equity ratio
38.8%
This company
38.2%
Market median
+2% vs market
2023
2024
Return on equity
-403.9%
This company
18.4%
Market median
-2295% vs market
2023
2024
Net profit margin
-188.4%
This company
8.1%
Market median
-2426% vs market
2023
2024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
2023
2024
Debt / equity
1.58×
This company
0.62×
Market median
-155% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TS
Tina Solvang Tungen
Chief Executive Officer
Chief Executive Officer
2024
MJ
Marco Josef Janezic
Observer
Observer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KM
Kathrine Mørtvedt Andersen
Chairman
2024
KJ
Karl-Heinz Josef Jansen
Board of Directors
2025
Former (1)
KB
Kristian Brekke Djuve
Chairman
2023 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nytt Foretak As
Company
100%
100%
2023
Norsk Medisinsk Syklotronsenter As
Company
93.02%
93.02%
2024
Khj Beteiligungs Gmbh
Company
6.98%
6.98%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ISOTOPES HOLDING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Tina Solvang Tungen
Chief Executive Officer
0 companies
Marco Josef Janezic
Observer
0 companies
Kathrine Mørtvedt Andersen
Chairman
0 companies
Karl-Heinz Josef Jansen
Board of Directors
0 companies
Kristian Brekke Djuve
Chairman
0 companies